Hypothalamic Neuropeptide Systems as Targets for Potential Anti-Obesity Drugs

E-ISSN： 1875-5607|7|1|11-19

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.7, Iss.1, 2007-01, pp. : 11-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of anti-obesity agents: drugs that target neuropeptide and neurotransmitter systems

By Fong Tung M

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 3, 2008-03 ,pp. : 321-325

Informa Healthcare

Access to resources Recommend Favorite

Neuropeptide Y1 and Y5 Receptor Antagonists as Potential Anti-Obesity Drugs: Current Status

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 11, 2014-10 ,pp. : 896-919

Bentham Science Publishers

Access to resources Recommend Favorite

Novel anti-obesity drugs

By Proietto J. Fam B.C. Ainslie D.A. Thorburn A.W.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 6, 2000-06 ,pp. : 1317-1326

Informa Healthcare

Access to resources Recommend Favorite

The anti-obesity potential of sigmoidin A

By Habtemariam Solomon

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 50, Iss. 12, 2012-12 ,pp. : 1519-1522

Informa Healthcare

Access to resources Recommend Favorite

Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status

By Parker E. Van Heek M. Stamford A.

European Journal of Pharmacology, Vol. 440, Iss. 2, 2002-04 ,pp. : 173-187

Elsevier

Access to resources Recommend Favorite